Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00848237 · ClinicalTrials.gov registry record · NA
HALO Patient Registry: Ablation of Barrett's Esophagus
A NA study of Barrett Esophagus, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 5,521
- Enrollment target
- 1
- Study location
NCT00848237: Completed NA study of Barrett Esophagus, sponsored by Medtronic - MITG.
NCT00848237 is a NA study of Barrett Esophagus that has completed, run by Medtronic - MITG. The registered enrollment target is 5,521 participants, above the 3,393-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00848237, a NA study of Barrett Esophagus, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,521 participants
- Enrollment target
- 1
- Study location
Study Summary
The HALO Patient Registry is a prospective/retrospective, multi-center patient registry. It provides a framework for treatment and follow-up of patients with Barrett's esophagus (non-dysplastic IM, LGD and HGD). The primary objective is to provide a tool for participating physician investigators to collect outcomes data related to the use of the HALO Ablation Systems.
Primary Outcome
% of patients with 100 % resolution at 1 year follow-up. This endpoint is a visual and not reliable or accurate. A better measure of clearance of Barrett's esophagus is based on biopsies.
Conditions Studied
Interventions
- DEVICE Radiofrequency Ablation (HALO Ablation Systems)
Study Locations (1)
California
- Gastrointestinal Associates and sites across the US - Knoxville and Other US Cities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,521 participants |
| Start Date | 2007-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT00848237 record still lists
NCT00848237 is an interventional study that assigns participants to a tested intervention. Its 5,521 participants enrollment target places it among the larger protocols in the corpus, above the 3,393-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (63% higher).
The record links to 1 condition, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Ablation (HALO Ablation Systems) is the first listed.
NCT00848237 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00848237 about?
NCT00848237 is a clinical study titled "HALO Patient Registry: Ablation of Barrett's Esophagus". The HALO Patient Registry is a prospective/retrospective, multi-center patient registry. It provides a framework for treatment and follow-up of patients with Barrett's esophagus (non-dysplastic IM, LGD and HGD). The primary objective is to provide a tool for participating physician investigators to ...
What is the current status of trial NCT00848237?
This trial is currently completed. It is a NA study. The enrollment target is 5,521 participants. The study started on 2007-07. Estimated completion is 2014-07.
What conditions does trial NCT00848237 study?
This clinical trial studies the following conditions: Barrett Esophagus.
What interventions are being tested in trial NCT00848237?
The interventions under investigation include: Radiofrequency Ablation (HALO Ablation Systems) (DEVICE).
Who is sponsoring clinical trial NCT00848237?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00848237 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00848237's enrollment target sits among peer trials
5,521 2nd of 32 the highest of 32 other Barrett Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia